(Q48419074)

English

Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice.

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

author name string

Javaloy J

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

Román JF

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

Vidal MT

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

Horga JF

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

796

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

1-2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

311-314

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

Calcium antagonist nimodipine in intractable epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900352-7

7 January 2021

Nifedipine for epilepsy? A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900352-7

7 January 2021

Antiepileptic drug actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900352-7

7 January 2021

Calcium, neuronal hyperexcitability and ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900352-7

7 January 2021

Cellular Action of Calcium Channel Blocking Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900352-7

7 January 2021

Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900352-7

7 January 2021

Correlation between anticonvulsant activity and plasma concentration of ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900352-7

7 January 2021

Identifiers

10.1016/S0006-8993(98)00352-7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9689485

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48419074&oldid=1372573776"